HRP20020334B1 - Proces za pripremu amorfnog kalcij-atorvastatina - Google Patents

Proces za pripremu amorfnog kalcij-atorvastatina

Info

Publication number
HRP20020334B1
HRP20020334B1 HR20020334A HRP20020334A HRP20020334B1 HR P20020334 B1 HRP20020334 B1 HR P20020334B1 HR 20020334 A HR20020334 A HR 20020334A HR P20020334 A HRP20020334 A HR P20020334A HR P20020334 B1 HRP20020334 B1 HR P20020334B1
Authority
HR
Croatia
Prior art keywords
atorvastatin
preparation
calcium
amorphic
heating
Prior art date
Application number
HR20020334A
Other languages
English (en)
Croatian (hr)
Inventor
Greff Zoltn
K�tay Nagy P�ter
Bark�czy J�zsef
Simig Gyula
Bal�zs L�szl�
Dom�n Imre
R�tkai Zolt�n
Seres P�ter
Szent Kir�llyi Zsuzsa
Bartha Ferenc
Vereczkeyn� Don�th Gy�rgyi
Nagy K�lm�n
Original Assignee
Egis Gy�gyszergy�r RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gy�gyszergy�r RT filed Critical Egis Gy�gyszergy�r RT
Publication of HRP20020334A2 publication Critical patent/HRP20020334A2/hr
Publication of HRP20020334B1 publication Critical patent/HRP20020334B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20020334A 1999-10-18 2000-10-17 Proces za pripremu amorfnog kalcij-atorvastatina HRP20020334B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9903634A HU226640B1 (en) 1999-10-18 1999-10-18 Process for producing amorphous atorvastatin calcium salt
PCT/HU2000/000106 WO2001028999A1 (en) 1999-10-18 2000-10-17 Process for the preparation of amorphous atorvastatin calcium

Publications (2)

Publication Number Publication Date
HRP20020334A2 HRP20020334A2 (en) 2004-02-29
HRP20020334B1 true HRP20020334B1 (hr) 2007-12-31

Family

ID=90014241

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20020334A HRP20020334B1 (hr) 1999-10-18 2000-10-17 Proces za pripremu amorfnog kalcij-atorvastatina

Country Status (17)

Country Link
EP (1) EP1235800B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003512354A (cg-RX-API-DMAC7.html)
KR (1) KR100664353B1 (cg-RX-API-DMAC7.html)
CN (1) CN1157374C (cg-RX-API-DMAC7.html)
AT (1) ATE345327T1 (cg-RX-API-DMAC7.html)
AU (1) AU1166301A (cg-RX-API-DMAC7.html)
CA (1) CA2388018C (cg-RX-API-DMAC7.html)
CZ (1) CZ300071B6 (cg-RX-API-DMAC7.html)
DE (1) DE60031882T2 (cg-RX-API-DMAC7.html)
HR (1) HRP20020334B1 (cg-RX-API-DMAC7.html)
HU (1) HU226640B1 (cg-RX-API-DMAC7.html)
PL (1) PL354604A1 (cg-RX-API-DMAC7.html)
RS (1) RS50473B (cg-RX-API-DMAC7.html)
RU (1) RU2255932C2 (cg-RX-API-DMAC7.html)
SK (1) SK286861B6 (cg-RX-API-DMAC7.html)
UA (1) UA72777C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001028999A1 (cg-RX-API-DMAC7.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7411075B1 (en) 2000-11-16 2008-08-12 Teva Pharmaceutical Industries Ltd. Polymorphic form of atorvastatin calcium
SI20425A (sl) * 1999-12-10 2001-06-30 LEK tovarna farmacevtskih in kemi�nih izdelkov d.d. Priprava amorfnega atorvastatina
US7501450B2 (en) 2000-11-30 2009-03-10 Teva Pharaceutical Industries Ltd. Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
IL156055A0 (en) 2000-11-30 2003-12-23 Teva Pharma Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms
WO2002057229A1 (en) 2001-01-19 2002-07-25 Biocon India Limited FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN)
DE10135493A1 (de) * 2001-07-20 2003-01-30 Jobst Krauskopf Pharmazeutische Zusammensetzung zur Behandlung von Hypercholesterinämie
AU2002255479B2 (en) 2001-07-30 2008-09-11 Dr. Reddy's Laboratories Ltd. Crystalline forms VI and VII of atorvastatin clacium
HUP0500074A3 (en) * 2002-03-18 2005-07-28 Biocon Ltd Bangalore Amorphous hmg-coa reductase inhibitors of desired particle size and process for producing them
RU2309141C2 (ru) * 2002-03-18 2007-10-27 Байокон Лимитид АМОРФНЫЕ ИНГИБИТОРЫ ГМГ-КоА-РЕДУКТАЗЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ
ITMI20020907A1 (it) * 2002-04-29 2003-10-29 Chemi Spa Processo di preparazione della forma amorfa del sale di calcio della atorvastatina
WO2003099785A1 (en) * 2002-05-28 2003-12-04 Cadila Healthcare Limited Process for the preparation of amorphous atorvastatin calcium
HU227041B1 (en) * 2003-03-24 2010-05-28 Richter Gedeon Nyrt Process for the synthesis of amorphous atorvastatin calcium
US7790197B2 (en) 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US7655692B2 (en) * 2003-06-12 2010-02-02 Pfizer Inc. Process for forming amorphous atorvastatin
US20050271717A1 (en) 2003-06-12 2005-12-08 Alfred Berchielli Pharmaceutical compositions of atorvastatin
CZ298382B6 (cs) * 2004-03-10 2007-09-12 Zentiva, A. S. Zpusob prípravy amorfní formy hemivápenaté soli atorvastatinu a její stabilizace
WO2005092852A1 (en) 2004-03-17 2005-10-06 Ranbaxy Laboratories Limited Process for the production of atorvastatin calcium in amorphous form
CN1960972A (zh) * 2004-04-16 2007-05-09 辉瑞产品公司 用于形成无定形阿托伐它汀钙的方法
CN1692906A (zh) * 2004-04-30 2005-11-09 鲁南制药集团股份有限公司 治疗高血脂症的组合物
CA2649054A1 (en) 2004-05-05 2005-11-10 Pfizer Products Inc. Salt forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
CA2573969C (en) * 2004-07-16 2014-02-04 Lek Pharmaceuticals D.D. Oxidative degradation products of atorvastatin calcium
JP2008506764A (ja) 2004-07-20 2008-03-06 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー ［Ｒ−（Ｒ＊，Ｒ＊）］−２−（４−フルオロフェニル）−β、δ−ジヒドロキシ−５−（１−メチルエチル）−３−フェニル−４−［（フェニルアミノ）カルボニル］−１Ｈ−ピロール−１−ヘプタン酸カルシウム塩（２：１）の新規形態
WO2006037125A1 (en) 2004-09-28 2006-04-06 Teva Pharmaceutical Industries Ltd. Process for preparing forms of atorvastatin calcium substantially free of impurities
CN101039906A (zh) * 2004-10-18 2007-09-19 特瓦制药工业有限公司 通过将盐溶解于有机溶剂并除去该溶剂来制备无定形阿托伐他汀半钙的方法，所述有机溶剂为醇和酮和 /或酯的混合物
WO2006046109A1 (en) 2004-10-28 2006-05-04 Warner-Lambert Company Llc Process for forming amorphous atorvastatin
ATE466840T1 (de) 2005-11-21 2010-05-15 Warner Lambert Co Neue formen von är-(r*,r*)ü-2-(4-fluorphenyl)-b,d-dihydroxy-5-( -methylethyl)-3-phenyl-4- ä(phenylamino)carbonylü-1h-pyrrol-1-heptansäure magnesium
EP1810667A1 (en) 2006-01-20 2007-07-25 KRKA, tovarna zdravil, d.d., Novo mesto Pharmaceutical composition comprising amorphous atorvastatin
KR100833439B1 (ko) * 2007-01-02 2008-05-29 씨제이제일제당 (주) 비결정형 아토르바스타틴 칼슘의 개선된 제조방법
CZ201039A3 (cs) 2010-01-19 2011-07-27 Zentiva, K. S Zpusob prumyslové výroby amorfní formy hemivápenaté soli (3R,5R) 7-[3-fenyl-4-fenylkarbamoyl-2-(4-fluorfenyl)-5-isopropylpyrrol-1-yl]-3,5-dihydroxyheptanové kyseliny (atorvastatinu) s vysokým specifickým povrchem a jeho použití v lékové forme
HUP1000299A2 (hu) 2010-06-08 2012-02-28 Nanoform Cardiovascular Therapeutics Ltd Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra
CN103274985B (zh) * 2010-12-03 2016-03-09 上海科州药物研发有限公司 一种阿托伐他汀氨基酸盐

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94339C (fi) * 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
ATE123020T1 (de) * 1990-05-11 1995-06-15 American Cyanamid Co N-acylierte arylpyrrole als insektizide, akarizide, nematizide und molluskizide wirkstoffe.
HRP960312B1 (en) * 1995-07-17 2001-10-31 Warner Lambert Co NOVEL PROCESS FOR THE PRODUCTION OF AMORPHOUS /R-(R*, R*)/-2-(4-FLUOROPHENYL)-"beta", "delta"-DIHYDROXY-5-PHENYL-4-/(PHENYLAMINO)CARBONYL/-1H-PYRROLE -1-HEPTANOIC ACID CALCIUM SALT (2 : 1)
WO1998012200A1 (en) * 1996-09-20 1998-03-26 Meiji Seika Kaisha Ltd. A crystalline substance of cefditoren pivoxyl and the production of the same

Also Published As

Publication number Publication date
HUP9903634A3 (en) 2002-01-28
RU2255932C2 (ru) 2005-07-10
RS50473B (sr) 2010-03-02
HU226640B1 (en) 2009-05-28
YU28302A (sh) 2005-06-10
CA2388018C (en) 2008-04-08
ATE345327T1 (de) 2006-12-15
EP1235800A1 (en) 2002-09-04
CA2388018A1 (en) 2001-04-26
CN1379760A (zh) 2002-11-13
HUP9903634D0 (en) 1999-12-28
DE60031882T2 (de) 2007-07-05
SK5192002A3 (en) 2002-11-06
WO2001028999A1 (en) 2001-04-26
CN1157374C (zh) 2004-07-14
KR20020063166A (ko) 2002-08-01
AU1166301A (en) 2001-04-30
HUP9903634A2 (hu) 2001-12-28
DE60031882D1 (de) 2006-12-28
HK1050199A1 (en) 2003-06-13
HRP20020334A2 (en) 2004-02-29
JP2003512354A (ja) 2003-04-02
PL354604A1 (en) 2004-01-26
SK286861B6 (sk) 2009-06-05
UA72777C2 (en) 2005-04-15
KR100664353B1 (ko) 2007-01-02
EP1235800B1 (en) 2006-11-15
CZ20021256A3 (cs) 2002-08-14
CZ300071B6 (cs) 2009-01-21

Similar Documents

Publication Publication Date Title
HRP20020334B1 (hr) Proces za pripremu amorfnog kalcij-atorvastatina
JP2003512354A5 (cg-RX-API-DMAC7.html)
Wojtas et al. Total synthesis of nosiheptide
BR9907936A (pt) Composição farmacêutica, composto, e, processo para preparar o mesmo
DE69203877D1 (de) Verfahren zur Vernichtung von photokatalytisch abbaubarem, organischem Stoff.
ATE429920T1 (de) Pharmazeutische zusammensetzung und verfahren zur behandlung von hypogonadismus
MX9203962A (es) Proceso para acondicionamiento de pigmentos organicos.
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
NO961693D0 (no) Delta16-umettede C17-heterocykliske steroider som er anvendbare som steroid C17-20-lyaseinhibitorer
DE69203878D1 (de) Verfahren zur Vernichtung von photokatalytisch abbaubarem, organischem Stoff.
de Figueiredo et al. Sequential One‐Pot Synthesis of Dipeptides through the Transient Formation of CDI‐N‐Protected α‐Aminoesters
DE69303935D1 (de) Verfahren zur Herstellung von 4-Bromomethylbiphenyl-Verbindungen
TR199900561T2 (xx) G-protein i�levinin engellenmesi i�in ve �o�almaya y�nelik hastal�klar�n iyile�tirilmesi i�in yararl� trisiklik bile�ikler.
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
DK0530639T3 (da) Heterocyclisk substituerede quinolylmethoxy-phenylacetamider som lipoxygenasehæmmere
Ingenito et al. Effect of copper salts on peptide bond formation using peptide thioesters
DE60232006D1 (de) Rückgewinnung und recycling chiraler weinsäureverbindungen zur racematspaltung
Xu et al. Conversion of nocathiacin I to nocathiacin acid by a mild and selective cleavage of dehydroalanine
Lin et al. Stereocontrolled formation of ketomethylene isosteres through tandem chain extension reactions
DE60032453D1 (de) Ein verfahren zur synthese von ritonavir
Kothakonda et al. Synthesis of a novel tetrahydroisoquinolino [2, 1-c][1, 4] benzodiazepine ring system with DNA recognition potential
CY1108756T1 (el) Μεθοδος για τον καθαρισμο διασερεϊνης
Airaksinen et al. One-Pot Synthesis of 3, 4-Disubstituted 1 H-Pyrroles from 2-Tropanones
Lo et al. A CD Exciton Chirality Method for Determination of the Absolute Configuration of t hreo-β-Aryl-β-hydroxy-α-amino Acid Derivatives
Alladoum et al. Enantioselective synthesis of β-amino-diacids

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20081006

Year of fee payment: 9

PBON Lapse due to non-payment of renewal fee

Effective date: 20091018